Determination of Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day

Condition:   Oral Mucositis
Interventions:   Biological: AG013;   Other: Placebo
Sponsor:   Oragenics, Inc.
Recruiting - verified July 2017

http://ift.tt/2vlIP41